Atlas Trials

Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration

Clinical trial NCT00764738 · COMPLETED

Trial details

NCT number
NCT00764738
Sponsor
Retina Macula Institute
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Neovascular Age Related Macular Degeneration
Start date
2008-10-01
Primary completion
2011-11-01
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.